Vimarsana
Biggest News Aggregation in the World

Eiger Onecare News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eiger Onecare. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eiger Onecare Today - Breaking & Trending Today

Eiger BioPharmaceuticals, Inc. (EIGR) CEO David Cory on Q1 2022 Results - Earnings Call Transcript - Vimarsana News

Eiger BioPharmaceuticals, Inc. (EIGR) CEO David Cory on Q1 2022 Results - Earnings Call Transcript

Eiger BioPharmaceuticals, Inc. (NASDAQ:NASDAQ:EIGR) Q1 2022 Earnings Conference Call May 5, 2022 04:30 PM ET Company Participants Sarah Mathieson - Senior Vice President-Corporate Affairs...

Ultrarare disease specialists top 2021's pricey drugs list, but Takeda, Merck KGaA meds rank, too - Vimarsana News

Ultrarare disease specialists top 2021's pricey drugs list, but Takeda, Merck KGaA meds rank, too

Mar 9, 2021 12:12pm Eiger BioPharmaceuticals' Zokinvy, recently approved by the FDA for ultrarare rapid-aging diseases that affect an estimated 600 children worldwide, is the most expensive drug in U.S. pharmacies in 2021, according to GoodRx.(Jacoblund) Eiger BioPharmaceuticals in November snagged FDA clearance for Zokinvy for ultra-rare rapid-aging diseases that affect an estimated 600 people worldwide. Orphan drugs that treat small patient populations typically come with high prices, but Zokinvy’s sticker price now beats them all in U.S. pharmacies. At an estimated monthly price of $86,0...